“Comparison Study of the Effect of Erlotinib As a Tyrosine Kinase Inhibitor on Electrolyte Levels in Type2 Diabetic and Diabetic Nephropathy”. 2018. Ibn AL-Haitham Journal For Pure and Applied Sciences 31 (3): 63-69. https://doi.org/10.30526/31.3.2011.